Patents by Inventor Zixin Deng

Zixin Deng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11796616
    Abstract: A method of performing multidimensional magnetic resonance imaging on a subject comprises collecting imaging data for a region of interest of the subject, the imaging data related to one or more spatially-varying parameters of the subject within the region of interest; collecting auxiliary data for the region of interest in the subject, the auxiliary data related to one or more time-varying parameters of the subject within the region of interest; linking the imaging data and the auxiliary data; and constructing an image tensor with one or more temporal dimensions based on at least a portion of the linked imaging data and at least a portion of the linked auxiliary data.
    Type: Grant
    Filed: May 28, 2021
    Date of Patent: October 24, 2023
    Assignee: CEDARS-SINAI MEDICAL CENTER
    Inventors: Debiao Li, Anthony Christodoulou, Zhaoyang Fan, Zixin Deng, Nan Wang, Zhengwei Zhou, Sen Ma, Christopher Nguyen, Yibin Xie, Jaime Shaw
  • Publication number: 20230212670
    Abstract: The present invention provides a rapid viral nucleic acid detection kit prepared by using a novel RecA enzyme and the detection method thereof. By editing the recombinase RecA gene, the expressed RecA protein has better solubility and recombinase activity. The RecA protein is used to prepare recombinase dry powder, further the formula of the recombinase dry powder and the ratio are optimized; and specific primers for the ASFV p72 gene are designed for the rapid nucleic acid detection of ASFV, significantly improving the detection sensitivity. In addition, the detection time is short, which effectively avoids missed detection and false detection, and helps prevention of epidemic.
    Type: Application
    Filed: June 28, 2022
    Publication date: July 6, 2023
    Inventors: Qi CHENG, Jinhui WANG, Dongjie HU, Jun CHEN, Zixin DENG
  • Publication number: 20210356544
    Abstract: A method of performing multidimensional magnetic resonance imaging on a subject comprises collecting imaging data for a region of interest of the subject, the imaging data related to one or more spatially-varying parameters of the subject within the region of interest; collecting auxiliary data for the region of interest in the subject, the auxiliary data related to one or more time-varying parameters of the subject within the region of interest; linking the imaging data and the auxiliary data; and constructing an image tensor with one or more temporal dimensions based on at least a portion of the linked imaging data and at least a portion of the linked auxiliary data.
    Type: Application
    Filed: May 28, 2021
    Publication date: November 18, 2021
    Inventors: Debiao Li, Anthony Christodoulou, Zhaoyang Fan, Zixin Deng, Nan Wang, Zhengwei Zhou, Sen Ma, Christopher Nguyen, Yibin Xie, Jaime Shaw
  • Patent number: 11022666
    Abstract: A method of performing multidimensional magnetic resonance imaging on a subject comprises collecting imaging data for a region of interest of the subject, the imaging data related to one or more spatially-varying parameters of the subject within the region of interest; collecting auxiliary data for the region of interest in the subject, the auxiliary data related to one or more time-varying parameters of the subject within the region of interest; linking the imaging data and the auxiliary data; and constructing an image tensor with one or more temporal dimensions based on at least a portion of the linked imaging data and at least a portion of the linked auxiliary data.
    Type: Grant
    Filed: May 8, 2019
    Date of Patent: June 1, 2021
    Assignee: Cedars-Sinai Medical Center
    Inventors: Debiao Li, Anthony Christodoulou, Zhaoyang Fan, Zixin Deng, Nan Wang, Zhengwei Zhou, Sen Ma, Christopher Nguyen, Yibin Xie, Jaime Shaw
  • Patent number: 10925510
    Abstract: Magnetic resonance imaging utilizing a continuous spoiled gradient echo sequence with 3D radial trajectory and 1D self-gating for respiratory motion detection can be used to characterize respirator motion in the abdomen. The resulting image data is acquired and is retrospectively sorted into different respiratory phases based on their temporal locations within a respiratory cycle, and each phase is reconstructed via a self-calibrating conjugate gradient sensitivity encoding (CG-SENSE) program.
    Type: Grant
    Filed: May 8, 2015
    Date of Patent: February 23, 2021
    Assignee: Cedars-Sinai Medical Center
    Inventors: Zhaoyang Fan, Jianing Pang, Zixin Deng, Debiao Li
  • Patent number: 10519203
    Abstract: A gene for biosynthesis of core structure of ophiobolin, the gene being the AuOS gene of Aspergillus sp. 094102, deposited with the accession number CCTCC No: M208153, the gene sequence thereof being shown as SEQ ID NO. 1. Also provided is a method of preparation of ophiobolin using the gene.
    Type: Grant
    Filed: September 22, 2017
    Date of Patent: December 31, 2019
    Assignee: WUHAN UNIVERSITY
    Inventors: Kui Hong, Huiying Meng, Hangzhen Chai, Ru Yin, Zixin Deng
  • Publication number: 20190346523
    Abstract: A method of performing multidimensional magnetic resonance imaging on a subject comprises collecting imaging data for a region of interest of the subject, the imaging data related to one or more spatially-varying parameters of the subject within the region of interest; collecting auxiliary data for the region of interest in the subject, the auxiliary data related to one or more time-varying parameters of the subject within the region of interest; linking the imaging data and the auxiliary data; and constructing an image tensor with one or more temporal dimensions based on at least a portion of the linked imaging data and at least a portion of the linked auxiliary data.
    Type: Application
    Filed: May 8, 2019
    Publication date: November 14, 2019
    Applicant: Cedars-Sinai Medical Center
    Inventors: Debiao Li, Anthony Christodoulou, Zhaoyang Fan, Zixin Deng, Nan Wang, Zhengwei Zhou, Sen Ma, Christopher Nguyen, Yibin Xie, Jaime Shaw
  • Publication number: 20180009855
    Abstract: A gene for biosynthesis of core structure of ophiobolin, the gene being the AuOS gene of Aspergillus sp. 094102, deposited with the accession number CCTCC No: M208153, the gene sequence thereof being shown as SEQ ID NO. 1. Also provided is a method of preparation of ophiobolin using the gene.
    Type: Application
    Filed: September 22, 2017
    Publication date: January 11, 2018
    Inventors: Kui HONG, Huiying MENG, Hangzhen CHAI, Ru YIN, Zixin DENG
  • Patent number: 9605015
    Abstract: The present invention relates to a novel polyene compound similar to nystatin, a method for preparing the same, and an antifungal drug comprising the novel polyene compound as an active ingredient. Compared to nystatin comprising one sugar, NNP, which is the polyene compound similar to nystatin, displays 300 times higher solubility and ten times lower cytotoxicity while maintaining antifungal activity, and thus can be useful in developing a novel polyene antifungal agent having improved solubility and less toxicity in terms of pharmacokinetics.
    Type: Grant
    Filed: August 31, 2012
    Date of Patent: March 28, 2017
    Assignee: INHA-INDUSTRY PARTNERSHIP INSTITUTE
    Inventors: Eung-Soo Kim, Kyu Boem Han, Shuangjun Lin, Dekun Kong, Linquan Bai, Zixin Deng, David H. Sherman, Mi-Jin Lee
  • Publication number: 20160324500
    Abstract: In some embodiments, the present application discloses utilizing a continuous spoiled gradient echo sequence with 3D radial trajectory and 1D self-gating for respiratory motion detection. In certain embodiments, data acquired are retrospectively sorted into different respiratory phases based on their temporal locations within a respiratory cycle, and each phase is reconstructed via a self-calibrating CG-SENSE program.
    Type: Application
    Filed: May 8, 2015
    Publication date: November 10, 2016
    Applicant: CEDARS-SINAI MEDICAL CENTER
    Inventors: Zhaoyang Fan, Jianing Pang, Zixin Deng, Debiao Li
  • Publication number: 20140371436
    Abstract: The present invention relates to a novel polyene compound similar to nystatin, a method for preparing the same, and an antifungal drug comprising the novel polyene compound as an active ingredient. Compared to nystatin comprising one sugar, NNP, which is the polyene compound similar to nystatin, displays 300 times higher solubility and ten times lower cytotoxicity while maintaining antifungal activity, and thus can be useful in developing a novel polyene antifungal agent having improved solubility and less toxicity in terms of pharmacokinetics.
    Type: Application
    Filed: August 31, 2012
    Publication date: December 18, 2014
    Applicant: INHA-INDUSTRY PARTNERSHIP INSTITUTE
    Inventors: Eung-Soo Kim, Kyu Boem Han, Shuangjun Lin, Dekun Kong, Linquan Bai, Zixin Deng, David H. Sherman, Mi-Jin Lee
  • Publication number: 20140308711
    Abstract: This invention relates to methods, compositions, and kits for enzymatic phosphorothioation of the sugar-phosphate backbone of nucleic acids. The invention allows for phosphorothioation of pre-existing nucleic acids.
    Type: Application
    Filed: March 13, 2014
    Publication date: October 16, 2014
    Applicants: Massachusetts Institute of Technology, Wuhan University, Shanghai Jiaotong University
    Inventors: Peter C. Dedon, Delin You, Bo Cao, Ramesh Babu Indrakanti, Michael S. DeMott, Lianrong Wang, Zixin Deng, Xiufen Zhou
  • Patent number: 8101732
    Abstract: This disclosure relates to validamycin A biosynthesis and in particular, to methods of producing validamycin A analogs and uses thereof. In a particular example, a method for making a validamycin A analog includes transforming a host cell with one or more recombinant DNA vectors to produce a valN-inactivated mutant; and culturing the valN-inactivated mutant in a culture medium to produce a validamycin A analog, such as 1,1?-bis-valienamine and validienamycin, and their conversion to valienamine. The present disclosure further relates to compositions including such compounds as well as methods of using the compositions, such as for antifungal agents.
    Type: Grant
    Filed: September 15, 2009
    Date of Patent: January 24, 2012
    Assignee: State of Oregon acting by and through the State Board of Higher Education on behalf of Oregon State University
    Inventors: Taifo Mahmud, Zixin Deng, Linquan Bai, Hui Xu, Jongtae Yang
  • Publication number: 20100151528
    Abstract: This disclosure relates to validamycin A biosynthesis and in particular, to methods of producing validamycin A analogs and uses thereof. In a particular example, a method for making a validamycin A analog includes transforming a host cell with one or more recombinant DNA vectors to produce a valN-inactivated mutant; and culturing the valN-inactivated mutant in a culture medium to produce a validamycin A analog, such as 1,1?-bis-valienamine and validienamycin, and their conversion to valienamine. The present disclosure further relates to compositions including such compounds as well as methods of using the compositions, such as for antifungal agents.
    Type: Application
    Filed: September 15, 2009
    Publication date: June 17, 2010
    Inventors: Taifo Mahmud, Zixin Deng, Linquan Bai, Hui Xu, Jongtae Yang
  • Patent number: 7595156
    Abstract: The present invention relates to the base sequence of whole genes involved in the biosynthesis of FR-008 polyketides derived from Streptomyces sp. FR-008. This base sequence comprises genes coding for ketosynthase (KS), acyl transferase (AT), acyl carrier protein (ACP), ketoreductase (KR), dehydratase (DH) and enoyl reductase (ER) domains, and genes coding for modifier enzymes, such as ABC transporter, cytochrome P450 monooxygenase, ferredoxin, thioesterase, sugar synthetic protein, FAD-dependent monooxygenase, 4-amino-4-deoxychorismate (ADC) synthase and ADC lyase. The gene base sequence according to the present invention can be used to increase the productivity of the existing FR-008 polyketides or produce new FR-008 polyketides, through modification of its parts.
    Type: Grant
    Filed: April 6, 2004
    Date of Patent: September 29, 2009
    Assignee: Korea Advanced Institute of Science and Technology
    Inventors: Sang Yup Lee, Zixin Deng, Shi Chen, Ki Jun Jeong, Xiufen Zhou
  • Publication number: 20050089884
    Abstract: The present invention relates to the base sequence of whole genes involved in the biosynthesis of FR-008 polyketides derived from Streptomyces sp. FR-008. This base sequence comprises genes coding for ketosynthase (KS), acyl transferase (AT), acyl carrier protein (ACP), ketoreductase (KR), dehydratase (DH) and enoyl reductase (ER) domains, and genes coding for modifier enzymes, such as ABC transporter, cytochrome P450 monooxygenase, ferredoxin, thioesterase, sugar synthetic protein, FAD-dependent monooxygenase, 4-amino-4-deoxychorismate (ADC) synthase and ADC lyase. The gene base sequence according to the present invention can be used to increase the productivity of the existing FR-008 polyketides or produce new FR-008 polyketides, through modification of its parts.
    Type: Application
    Filed: April 6, 2004
    Publication date: April 28, 2005
    Inventors: Sang Lee, Zixin Deng, Shi Chen, Ki Jeong, Xiufen Zhou